Aducanumab ' s Promise in Early Alzheimer ' s Aducanumab ' s Promise in Early Alzheimer ' s

Dr Christoph Diener discusses how this monoclonal antibody reduced amyloid-beta plaques and slowed cognitive decline in an initial study.Medscape Neurology
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Commentary Source Type: news